Oruka Therapeutics (ORKA) Capital Expenditures (2010 - 2026)
Oruka Therapeutics' quarterly Capital Expenditures came in at $73000.0 in Q1 2026, up 461.54% year-on-year from $13000.0 in Q1 2025, and up 15.87% quarter-over-quarter from $63000.0 in Q4 2025.
Oruka Therapeutics has reported Capital Expenditures for 15 years, with the latest figure at $73000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 461.54% year-over-year to $73000.0; the trailing twelve-month figure through Mar 2026 stood at $269000.0 (up 767.74% YoY), and the FY2025 full-year result was $209000.0, up 10.58% from the prior year.
- Capital Expenditures for Q1 2026 stood at $73000.0, up from $63000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $99000.0 in Q3 2025, with the low at $2000.0 in Q1 2022.
- Average Capital Expenditures over 4 years is $43142.9, with a median of $34000.0 recorded in 2025.
- Year-over-year, Capital Expenditures sank 33.33% in 2022 and jumped 461.54% in 2026.
- Tracing ORKA's Capital Expenditures over 4 years: stood at $2000.0 in 2022, then jumped by 800.0% to $18000.0 in 2024, then soared by 250.0% to $63000.0 in 2025, then gained by 15.87% to $73000.0 in 2026.
- The last three Capital Expenditures figures came in at $73000.0 (Q1 2026), $63000.0 (Q4 2025), and $99000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 73,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,000.00 |
| Mar 31, 2026 | 73,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2016 | 4,000.00 |
| Dec 31, 2016 | 4,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 1,000.00 |
| Mar 31, 2016 | 1,000.00 |
| Dec 31, 2015 | 2,000.00 |
| Dec 31, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Mar 31, 2015 | 2,000.00 |
| Mar 31, 2015 | 2,000.00 |
| Dec 31, 2014 | 14,000.00 |
| Dec 31, 2014 | 14,000.00 |
| Dec 31, 2013 | 4,000.00 |
| Dec 31, 2013 | 4,000.00 |
| Sep 30, 2013 | 11,000.00 |
| Sep 30, 2013 | 11,000.00 |
| Jun 30, 2013 | 8,000.00 |
| Jun 30, 2013 | 8,000.00 |
| Mar 31, 2013 | 9,000.00 |
| Mar 31, 2013 | 9,000.00 |
| Dec 31, 2011 | 18,000.00 |
| Dec 31, 2011 | 18,000.00 |
| Mar 31, 2011 | 1,000.00 |
| Mar 31, 2011 | 1,000.00 |
| Dec 31, 2010 | 2,000.00 |
| Dec 31, 2010 | 2,000.00 |